Cereno Scientific Balance Sheet Health
Financial Health criteria checks 2/6
Cereno Scientific has a total shareholder equity of SEK230.7M and total debt of SEK90.4M, which brings its debt-to-equity ratio to 39.2%. Its total assets and total liabilities are SEK345.3M and SEK114.6M respectively.
Key information
39.2%
Debt to equity ratio
SEK 90.40m
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 73.84m |
| Equity | SEK 230.73m |
| Total liabilities | SEK 114.55m |
| Total assets | SEK 345.28m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4A1's short term assets (SEK78.5M) exceed its short term liabilities (SEK24.2M).
Long Term Liabilities: 4A1's short term assets (SEK78.5M) do not cover its long term liabilities (SEK90.4M).
Debt to Equity History and Analysis
Debt Level: 4A1's net debt to equity ratio (7.2%) is considered satisfactory.
Reducing Debt: 4A1's debt to equity ratio has increased from 0.6% to 39.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4A1 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 4A1 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 39.4% each year